Targeting PI3K signalling in cancer: opportunities, challenges and limitations

Engelman, Jeffrey A.·2009·Nature Reviews Cancer

DOI 10.1038/nrc2664

Cited by (1,005)

Items 401–500 of 1,005

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Alex Friedlaender, Giuseppe Luigi Banna, Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo · 2019 · Frontiers in Oncology
The Akt signaling pathway
SubbaRao V. Madhunapantula, Paul J. Mosca, Gavin P. Robertson · 2011 · Cancer Biology & Therapy
Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
Yixiang Zhang, Jolieke G. van Oosterwijk, Ewa Sicińska, Samuel Moss, Stephen P. Remillard, Tom van Wezel, Claudia Bühnemann, Andrew Bassim Hassan, George D. Demetri, Judith V.M.G. Bovée et al. · 2013 · Clinical Cancer Research
Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology
Guo, Sun-Wei · 2020 · Human Reproduction Update
Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial
Joseph David Khoury, Wei‐Lien Wang, Victor Gerardo Prieto, Leonard Jeffrey Medeiros, Neda Kalhor, Meera Hameed, Russell R. Broaddus, Stanley R. Hamilton · 2017 · Clinical Cancer Research
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4- d ]pyrimidine scaffold
Daniel J. Baillache, Asier Unciti‐Broceta · 2020 · RSC Medicinal Chemistry
PHLPP-Mediated Dephosphorylation of S6K1 Inhibits Protein Translation and Cell Growth
Jianyu Liu, Payton D. Stevens, Xin Li, Micheal D. Schmidt, Tianyan Gao · 2011 · Molecular and Cellular Biology
Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research
Ingrid Øra, Angelika Eggert · 2011 · Seminars in Cancer Biology
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
Patrick Schöffski, Sara Cresta, Ingrid A. Mayer, Hans P. M. W. Wildiers, Silvia Damian, Steven B. Gendreau, Isabelle Anne Rooney, Kari M. Morrissey, Jill M. Spoerke, Vivian Ng et al. · 2018 · Breast Cancer Research
PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases
Petra Hillmann, Doriano Fabbro · 2019 · International Journal of Molecular Sciences
Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
Ming-Zhe Li, Huahu Guo, Qi Wang, Kai Chen, Kornmann Marko, Xiao-Dong Tian, Yin-Mo Yang · 2020 · Cancer Letters
Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN-γ+IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
Neil A. Marshall, Karen C. Galvin, Anna-Maria B. Corcoran, Louis Boon, Rowan Higgs, Kingston H. G. Mills · 2011 · Cancer Research
Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis
Sanja Coso, Yiping Zeng, Kenneth Opeskin, Elizabeth D. Williams · 2012 · PLoS ONE
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
Rachana Patel, Meiling Gao, Imran Ahmad, Janis Fleming, Lukram Babloo Singh, Taranjit Singh, Arthur B. McKie, Morag M. Seywright, Robert J. Barnetson, Joanne Edwards et al. · 2013 · Journal of Clinical Investigation
Bad phosphorylation as a target of inhibition in oncology
Bui, Ngoc-Linh-Chi, Pandey, Vijay, Zhu, Tao, Ma, Lan, Basappa, Lobie, Peter E. · 2018 · Cancer Letters
micro RNA ‐133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR / A kt signaling pathway
Wenjing Cui, Shuai Zhang, Changliang Shan, Li Zhou, Zhemin Zhou · 2013 · FEBS Journal
Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment
Irene Braña, Lillian L. Siu · 2012 · BMC Medicine
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
Pamela N. Münster, Monica M Mita, Amit Mahipal, John J. Nemunaitis, Christophe Massard, Tom Mikkelsen, Cristina Cruz, Luis G Paz-Ares, Manuel M. Hidalgo, Dana E. Rathkopf et al. · 2019 · Cancer Management and Research
Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells
Yumi Fujimoto, Tomoko Morita, Akihiro Ohashi, Hiroshi Haeno, Yumi Hakozaki, Masanori Fujii, Yukie Kashima, Susumu S. Kobayashi, Toru Mukohara · 2020 · Scientific Reports
Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells
Peter B. Makhov, Konstantin V. Golovine, Alexander Kutikov, Ervin Teper, Daniel J. Canter, Jay Simhan, Robert G. Uzzo, Vladimir M. Kolenko · 2012 · Molecular Cancer Therapeutics
AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
Timothy Anthony Yap, Mike I. Walton, Kyla M. Grimshaw, Robert te Poele, Paul D. Eve, Melanie R. Valenti, Alexis K. de Haven Brandon, Vanessa Martins, Anna Zetterlund, Simon P. Heaton et al. · 2012 · Clinical Cancer Research
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis
Andrew J. O’Brien, Linda A. Villani, Lindsay A. Broadfield, Vanessa P. Houde, Sandra Galić, Giovanni Blandino, Bruce E. Kemp, Theodoros K. Tsakiridis, Paola C. Muti, Gregory R. Steinberg · 2015 · Biochemical Journal
Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
Claudia Gasch, Brendan Ffrench, John J. O’Leary, Michael F. Gallagher · 2017 · Molecular Cancer
Genome-wide identification of transcription factors that are critical to non-small cell lung cancer
Da-Lin Zhang, Li-Wei Qu, Liang Ma, Yongchun Zhou, Guizhen Wang, Xinchun Zhao, Chen Zhang, Yanfei Zhang, Min Wang, Meiying Zhang et al. · 2018 · Cancer Letters
Hypoglycemic effects of polysaccharides from corn silk (Maydis stigma) and their beneficial roles via regulating the PI3K/Akt signaling pathway in L6 skeletal muscle myotubes
Qingwen Guo, Zhongqin Chen, Ramesh Kumar Santhanam, Leilei Xu, Xudong Gao, Qiqi Ma, Zihan Xue, Hạixia Chen · 2018 · International Journal of Biological Macromolecules
Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action
Jinfang Chen, Shiwei Wu, Zi-Man Shi, Bing Hu · 2023 · Chinese Medicine
Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα
Mariana Nacht, Lixin Qiao, Michael P. Sheets, Thia St Martin, Matthew Labenski, Hormoz Mazdiyasni, Russell Karp, Zhendong Zhu, Prasoon Chaturvedi, Deepa Bhavsar et al. · 2013 · Journal of Medicinal Chemistry
Emerging roles of PDGF-D in EMT progression during tumorigenesis
Qiong Wu, Xin Hou, Jun Xia, Xiujuan Qian, Lucio Miele, Fazlul H. Sarkar, Zhiwei Peter Wang · 2012 · Cancer Treatment Reviews
CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas
Michael D. Oberst, Stacy R. Fuhrmann, Kathy A. Mulgrew, Maria Amann, Lily Cheng, Petra Lutterbuese, Laura K. Richman, Steve Coats, Patrick A. Baeuerle, Scott A. Hammond · 2014 · mAbs
Inhibition of PI3Kβ Signaling with AZD8186 Inhibits Growth of PTEN-Deficient Breast and Prostate Tumors Alone and in Combination with Docetaxel
Urs J Hancox, S. Cosulich, Lyndsey Hanson, C. Trigwell, Carol Lenaghan, Rebecca P A Ellston, H. Dry, C. Crafter, B. Barlaam, M. Fitzek et al. · 2014 · Molecular Cancer Therapeutics
Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
Lisa D. Yee, Joanne E. Mortimer, Rama D Natarajan, Eric C. Dietze, Victoria L. Seewaldt · 2020 · Frontiers in Endocrinology
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Hiu‐Fung Yuen, Ka-Kui Chan, Claire Grills, James T. Murray, Angela M. Platt-Higgins, Osama Sharaf Eldin, Kenneth John O'Byrne, Pasi Antero Janne, Dean Anthony Fennell, Patrick G. Johnston et al. · 2011 · Clinical Cancer Research
PTEN-Deficient Tumors Depend on AKT2 for Maintenance and Survival
Y. Rebecca Chin, Xin Yuan, Steven P. Balk, Alex Toker · 2014 · Cancer Discovery
PI3K/Akt Cooperates with Oncogenic Notch by Inducing Nitric Oxide-Dependent Inflammation
Santiago Nahuel Villegas, Rita Gombos, Lucia García-López, Irene Gutiérrez-Pérez, Jesús García‐Castillo, Diana M. Vallejo, Vanina Gabriela Da Ros, Esther Ballesta‐Illán, József Mihály, María Domínguez · 2018 · Cell Reports
Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer
Sivaram, Nithya, McLaughlin, Patrick A., Han, Han V., Petrenko, Oleksi, Jiang, Ya-Ping, Ballou, Lisa M., Pham, Kien, Liu, Chen, van der Velden, Adrianus W.M., Lin, Richard Z. · 2019 · Journal of Clinical Investigation
The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
Chao Wang, Jun Ma, Nan Zhang, Qianlan Yang, Yue Jin, Yu Wang · 2015 · Expert Review of Anticancer Therapy
Bromelain inhibits nuclear factor kappa‐B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G2/M arrest to apoptosis
Kulpreet Bhui, Shilpa Tyagi, Amit Kumar Srivastava, Madhulika Singh, Preeti Roy, Richa Singh, Yogeshwer Shukla · 2011 · Molecular Carcinogenesis
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer
Lloye M. Dillon, Jennifer R. Bean, Wei Yang, Kevin Shee, Lynn Katherine Symonds, Justin Micah Balko, William Hayes McDonald, S. Liu, Ana Maria Gonzalez-Angulo, Gordon Brent Mills et al. · 2014 · Oncogene
A kinase-independent function of AKT promotes cancer cell survival
Igor Vivanco, Zhi C Chen, Barbara E. Tanos, Barbara Oldrini, Wan-Ying Hsieh, Nicolas A. Yannuzzi, Carl Campos, Ingo K. Mellinghoff · 2014 · eLife
Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma
Yasuhiro Oki, Michelle A. Fanale, Jorge Enrique Romaguera, Luis Fayad, Nathan Hale Fowler, Amanda R. M. Copeland, Felipe Samaniego, Larry W. Kwak, Sattva Swarup Neelapu, Michael L. Wang et al. · 2015 · British Journal of Haematology
Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer
Yosuke Togashi, Akihiro Kogita, Hiroki Sakamoto, Hidetoshi Hayashi, Masato Terashima, Marco Antonio De Velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Masayuki Kitano et al. · 2014 · Cancer Letters
Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways
Akira Nabeshima, Yoshihiro Matsumoto, Jun‐ichi Fukushi, Kunio Iura, Tomoya Matsunobu, Makoto Endo, Toshifumi Fujiwara, Kei-ichiro Iida, Yasuhiro Fujiwara, M Hatano et al. · 2015 · British Journal of Cancer
Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots
Shao-Hua Yang, Wenjun Li, Nathalie Sumien, Michael J. Forster, James W. Simpkins, Ran Liu · 2015 · Progress in Neurobiology
Insights Into the Antiviral Pathways of the Silkworm Bombyx mori
Liang Jiang · 2021 · Frontiers in Immunology
The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions
Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Ali Pirsalehi, Ava Safaroghli‐Azar, Mohammad Reza Zali, Davood Bashash · 2021 · European Journal of Pharmacology
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life
Giovanni Grandi, Angela Toss, Laura Cortesi, Laura Botticelli, Annibale Volpe, Angelo Cagnacci · 2015 · BioMed Research International
Autophagy in airway diseases: a new frontier in human asthma?
Amir A. Zeki, Behzad Yeganeh, Nicholas J. Kenyon, Martin Post, Saeid Ghavami · 2015 · Allergy
PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models
Fan Lin, Mark C. de Gooijer, Diana Hanekamp, Gayathri Chandrasekaran, Levi C.M. Buil, Nishita Thota, Rolf W. Sparidans, Jos H. Beijnen, Tom Würdinger, Olaf van Tellingen · 2016 · Clinical Cancer Research
Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis
Lin He, Xinhua Liu, Jianguo Yang, Wanjin Li, Shumeng Liu, Xujun Liu, Ziran Yang, Jie Ren, Yue Wang, Lin Shan et al. · 2018 · Cell Research
Signaling Pathways Mediating Alcohol Effects
Dorit Ron A, Robert O. Messing · 2011 · Current topics in behavioral neurosciences
Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications
Jiezhong Chen · 2012 · World Journal of Virology
Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers
Yoshifumi Baba, Katsuhiko Nosho, Kaori Shima, Marika Hayashi, Jeffrey A. Meyerhardt, Andrew Tan Chan, Edward L. Giovannucci, Charles S. Fuchs, Shuji Ogino · 2010 · Cancer
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
David S.P. Tan, Rowan E. Miller, Stan B. Kaye · 2013 · British Journal of Cancer
Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055)
Sarah V. Holt, Armelle Logié, Barry R. Davies, Denis Alférez, Sarah K. Runswick, Sarah Elizabeth Fenton, Christine M. Chresta, Yi Gu, Jingchuan Zhang, Yi-Long Lung Cancer Wu et al. · 2012 · Cancer Research
Mitochondrial Retrograde Signaling Mediated by UCP2 Inhibits Cancer Cell Proliferation and Tumorigenesis
Pauline Estèves, Claire Pecqueur, Céline Ransy, Catherine Esnous, Véronique Lenoir, Frédéric Bouillaud, Anne‐Laure Bulteau, Anne Lombès, Carina Prip‐Buus, Daniel Ricquier et al. · 2014 · Cancer Research
Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer
Yasutaka Sukawa · 2012 · World Journal of Gastroenterology
Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
Yunhe Gao, Kecheng Zhang, Hongqing Xi, Aizhen Cai, Xiaosong Wu, Jianxin Cui, Jiyang Li, Zhi Qiao, Bo Wei, Lin Chen · 2016 · Oncotarget
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
Isabelle Treilleux, Mónica Arnedos, Claire Cropet, Qianshan Wang, J-M Ferrero, Sophie Abadie‐Lacourtoisie, Christelle Lévy, Éric Legouffe, Alain H. Lortholary, Éric Pujade-Lauraine et al. · 2014 · Annals of Oncology
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2 -Amplified Breast Cancers
Meghan M. Joly, Donna J. Hicks, Bayley A. Jones, Violeta M. Sanchez, Monica Valeria Estrada, Christian D. Young, Michelle M. Williams, Brent Neil Rexer, Dos D. Sarbassov, William J. Muller et al. · 2016 · Cancer Research
Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms
Christine Unger, Nina Kramer, Daniela Unterleuthner, Martin Scherzer, Alexandra Burian, Albin Rudisch, Mira Stadler, Michaela Schlederer, D Lenhardt, Angelika Riedl et al. · 2017 · Oncogene
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients With Cancer
Angela Espósito, Giulia Viale, Giuseppe Curigliano · 2019 · JAMA Oncology
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
Florian Ewald, Nicole Grabinski, Astrid Grottke, Sabine Windhorst, Dominik Sebastian Nörz, Lisa Carstensen, Katharina Staufer, Bianca T. Hofmann, Frank Diehl, Kerstin A. David et al. · 2013 · International Journal of Cancer
The role of periostin in neoplastic processes
Katarzyna Ratajczak‐Wielgomas, Piotr Dzięgiel · 2015 · Folia Histochemica et Cytobiologica
Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity
Poulomi Bhattacharya, Aileen F. Keating · 2012 · Toxicology and Applied Pharmacology
AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
Ramachandran Rashmi, Carl J. DeSelm, Cynthia A. Helms, Anne M. Bowcock, Buck E. Rogers, Janet Sue Rader, Perry W. Grigsby, Julie Kristina Schwarz · 2014 · PLoS ONE
Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Inhibition and Biomarker Modulation by the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941
Laurent Salphati, Harvey Wong, Marcia P. Belvin, Delia Bradford, Kyle A. Edgar, Wei Wei Prior, Deepak Sampath, Jeffrey J. Wallin · 2010 · Drug Metabolism and Disposition
PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
Sherene Loi, Stefan Michiels, Jose M Baselga, John M.S. Bartlett, Sandeep Kumar Singhal, Vicky S. Sabine, Andrew H. Sims, Tarek Sahmoud, J. Michael Dixon, Martine J Piccart et al. · 2013 · PLoS ONE
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth
Michèle C. Smith, Mary M. Mader, James A. Cook, Philip W. Iversen, Rose T. Ajamie, Everett J. Perkins, Laura J. Bloem, Yvonne Y. Yip, David A. Barda, Philip P. Waid et al. · 2016 · Molecular Cancer Therapeutics
Autophagy in hypoxic ovary
Anil Kumar Yadav, Pramod K. Yadav, Govind R. Chaudhary, Meenakshi Tiwari, Anumegha Gupta, Alka Sharma, Ashutosh N. Pandey, Ajai Kumar Pandey, Shail Kumar Chaube · 2019 · Cellular and Molecular Life Sciences
Influence of the Mediterranean Diet on Healthy Aging
María Carmen Andreo-López, Victoria Contreras-Bolívar, Manuel Muñoz‐Torres, Beatriz García-Fontana, Cristina García‐Fontana · 2023 · International Journal of Molecular Sciences
Systematic Quantification of Negative Feedback Mechanisms in the Extracellular Signal-regulated Kinase (ERK) Signaling Network
Murat Cirit, Chun‐Chao Wang, Jason M. Haugh · 2010 · Journal of Biological Chemistry
Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities
Tan Li, Guanyu Wang · 2014 · International Journal of Molecular Sciences
Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality
Mayumi Kitagawa, Pei-Ju Liao, Kyung Hee Lee, Jasmine Wong, See Cheng Shang, Noriaki Minami, Oltea Sampetrean, Hideyuki Saya, Lingyun Dai, Nayana Prabhu et al. · 2017 · Nature Communications
Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
Koustas, Evangelos, Karamouzis, Michalis V., Mihailidou, Chrysovalantou, Schizas, Dimitrios, Papavassiliou, Athanasios G. · 2017 · Cancer Letters
ILT4 drives B7‐H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7‐H3 co‐expression correlates with poor prognosis in non‐small cell lung cancer
Pei Zhang, Shuwen Yu, Hongyu Li, Chuanyong Liu, Juan Li, Wenli Lin, Aiqin Gao, Linlin Wang, Wei Gao, Yuping Sun · 2015 · FEBS Letters
AKT-independent PI3-K signaling in cancer – emerging role for SGK3
Ross D. Hannan, Bruhn, Rick Pearson, Sheppard · 2013 · Cancer Management and Research
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer
Maura N. Dickler, Cristina Saura, Donald Richards, Ian E. Krop, Andrès M.R. Cervantes, Philippe Lucien Bedard, Manish R. Patel, Lajos Pusztai, Mafalda Oliveira, Alison K. Cardenas et al. · 2018 · Clinical Cancer Research
Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis
Hideki Yamaguchi, Tsukasa Oikawa · 2010 · Oncotarget
Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402
Christoph M. Dehnhardt, Aranapakam M. Venkatesan, Efren Delos Santos, Zecheng Chen, Osvaldo dos Santos, Semiramis Ayral‐Kaloustian, Natasja Brooijmans, Robert G. Mallon, Irwin J. Hollander, Larry R. Feldberg et al. · 2009 · Journal of Medicinal Chemistry
Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway
Peiwen Yu, Alexander Laird, Xiangnan Du, Jianming Wu, Kwang‐Ai Won, Toshihiro Yamaguchi, Pin P. Hsu, Fawn Qian, Christopher T. Jaeger, Wentao Zhang et al. · 2014 · Molecular Cancer Therapeutics
Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
Timothy Anthony Yap, Mike I. Walton, Lisa-Jane K. Hunter, Melanie R. Valenti, Alexis de Haven Brandon, Paul D. Eve, Ruth R. Ruddle, Simon P. Heaton, Alan T. Henley, Lisa Pickard et al. · 2010 · Molecular Cancer Therapeutics
Synergistic Induction of Apoptosis in Brain Cancer Cells by Targeted Codelivery of siRNA and Anticancer Drugs
Cheoljin Kim, Birju P. Shah, Prasad Subramaniam, Ki‐Bum Lee · 2011 · Molecular Pharmaceutics
FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression
Marten Hornsveld, Lydia M.M. Smits, Maaike Meerlo, Miranda van Amersfoort, Marian J.A. Groot Koerkamp, Dik van Leenen, David E.A. Kloet, Frank C. P. Holstege, Patrick W.B. Derksen, Boudewijn M.T. Burgering et al. · 2018 · Cancer Research
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
Nithikoon Aksorn, Pithi Chanvorachote B · 2019 · Anticancer Research
Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235
Connor P. Hall, C. Patrick Reynolds, Min H. Kang · 2015 · Clinical Cancer Research
The dual PI3K/mTOR inhibitor NVP‐BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial‐lysosomal cross‐talk
Christian Martin Seitz, Manuela Hugle, Silvia Cristofanon, Aurélie Tchoghandjian, Simone Fulda · 2012 · International Journal of Cancer
Interrogating Two Schedules of the AKT Inhibitor MK-2206 in Patients with Advanced Solid Tumors Incorporating Novel Pharmacodynamic and Functional Imaging Biomarkers
Timothy Anthony Yap, Yan Li, Amita Patnaik, Nina Tunariu, Andrea Biondo, Ivy Fearen, Kyriakos P. Papadopoulos, David Olmos, Richard D. Baird, Liliana Delgado et al. · 2014 · Clinical Cancer Research
AKT is a therapeutic target in myeloproliferative neoplasms
Irum Khan, Zan Huang, Q Wen, Monika J. Stankiewicz, L Gilles, Benjamin Goldenson, R Schultz, Lauren P. Diebold, Sandeep K. Gurbuxani, Christy M. Finke et al. · 2013 · Leukemia
Phosphoproteomic Analysis Implicates the mTORC2-FoxO1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases
Guanglei Zhuang, Kebing Yu, Zhaoshi Jiang, Alicia S. Chung, Jenny J. Yao, Connie Ha, Karen J. Toy, Robert H. Soriano, Benjamin Haley, Elizabeth R. Blackwood et al. · 2013 · Science Signaling
Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells
Ju‐Hong Jeon · 2011 · International Journal of Oncology
Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
Mingxiang Ye, Yong Zhang, Hongjun Gao, Yan Xu, Pengyu Jing, Jianxiong Wu, Xinxin Zhang, Jie Xiong, Chenfang Dong, Libo Yao et al. · 2017 · Clinical Cancer Research
Advances in Targeted Therapies for Triple-Negative Breast Cancer
Kelly Elizabeth McCann, Sara Alsterlind Hurvitz, Nicholas Patrick McAndrew · 2019 · Drugs
Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition
Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura, Rikio Suzuki, Hiroto Ohguchi, Ola Rizq, Shohei Kikuchi, Yasuhiro Yoshida, Francesca Cottini, Jana Jakubı́ková et al. · 2014 · Cancer Research
Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer
Chandan Rana, Honit Piplani, Vivek Vaish, Bimla Nehru, Sankar Nath Sanyal · 2015 · Molecular and Cellular Biochemistry
Pathologic Scoring of PTEN Immunohistochemistry in Endometrial Carcinoma is Highly Reproducible
Karuna Garg, Russell R. Broaddus, Robert A. Soslow, Diana L. Urbauer, Douglas A. Levine, Bojana Djordjevic · 2011 · International Journal of Gynecological Pathology
Sense and Sensitivity: FOXO and ROS in Cancer Development and Treatment
Stephen S. Myatt, Jan Joris Brosens, Eric W.‐F. Lam · 2010 · Antioxidants and Redox Signaling
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
Sandrine Boyault, Youenn Drouet, Claudine Navarro, Thomas Bachelot, Christine Lasset, Isabelle Treilleux, Éric Tabone, Alain Puisieux, Qing Wang · 2011 · Breast Cancer Research and Treatment
Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment
Yanyan Wang, Hong Zhe, Ren Zhao · 2014 · Molecular Cancer
Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
Mengqiu Song, Xuejiao Liu, Kangdong Liu, Ran Zhao, Hai Huang, Yuanyuan Shi, Man Zhang, Silei Zhou, Hua Xie, Hanyong Chen et al. · 2018 · Molecular Cancer Therapeutics
Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells
Tsukasa Nakamura, Toshimasa Nakao, Norio Yoshimura, Eishi Ashihara · 2015 · American Journal of Transplantation